ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $42,000 | -89.2% | 11,315 | -91.6% | 0.02% | -86.0% |
| Q4 2017 | $390,000 | -25.7% | 135,445 | +15.8% | 0.18% | -28.8% |
| Q3 2017 | $525,000 | -1.9% | 116,945 | +0.3% | 0.25% | -8.1% |
| Q2 2017 | $535,000 | +400.0% | 116,630 | +358.6% | 0.27% | +369.0% |
| Q1 2017 | $107,000 | +15.1% | 25,430 | +13.4% | 0.06% | +16.0% |
| Q4 2016 | $93,000 | -4.1% | 22,430 | +88.0% | 0.05% | -3.8% |
| Q3 2016 | $97,000 | – | 11,930 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,700,000 | $82,075,000 | 8.82% |
| RTW INVESTMENTS, LP | 1,622,633 | $19,877,000 | 7.35% |
| ProQuest Associates IV LLC | 1,122,957 | $13,757,000 | 6.97% |
| RA Capital Management | 2,500,000 | $30,625,000 | 3.29% |
| DOHENY ASSET MANAGEMENT /CA | 517,450 | $6,339,000 | 3.03% |
| DAFNA Capital Management LLC | 197,500 | $2,419,000 | 1.91% |
| Rhenman & Partners Asset Management AB | 368,000 | $4,508,000 | 1.31% |
| SECTORAL ASSET MANAGEMENT INC | 2,373,810 | $29,079,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,920,300 | $35,774,000 | 1.28% |
| Bain Capital Public Equity Management, LLC | 2,928,750 | $35,877,000 | 0.90% |